OpenAI Researcher Miles Wang in Talks for $2B Drug Discovery Startup
OpenAI researcher Miles Wang is in talks to raise $200 million at a $2 billion valuation for an AI startup targeting drug repurposing and discovery, with Lightspeed Venture Partners in early discussions.

Follow